Nuwellis, Inc. (NUWE)
USD 0.84
(-12.5%)
USD 0.84
(-12.5%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.78 Million USD | -44.95% |
| 2022 | 12.31 Million USD | 175.53% |
| 2021 | 4.47 Million USD | 21.01% |
| 2020 | 3.69 Million USD | 2.27% |
| 2019 | 3.61 Million USD | 27.18% |
| 2018 | 2.84 Million USD | 28.1% |
| 2017 | 2.21 Million USD | -61.2% |
| 2016 | 5.71 Million USD | -53.92% |
| 2015 | 12.39 Million USD | 292.62% |
| 2014 | 3.15 Million USD | -9.85% |
| 2013 | 3.5 Million USD | 67.85% |
| 2012 | 2.08 Million USD | -26.38% |
| 2011 | 2.83 Million USD | 519.63% |
| 2010 | 457.53 Thousand USD | 32.4% |
| 2009 | 345.55 Thousand USD | 48.3% |
| 2008 | 233.01 Thousand USD | 6.58% |
| 2007 | 218.62 Thousand USD | -40.35% |
| 2006 | 366.53 Thousand USD | 8.64% |
| 2005 | 337.38 Thousand USD | -73.43% |
| 2004 | 1.26 Million USD | 687.14% |
| 2003 | 161.33 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 13.02 Million USD | 125.43% |
| 2024 Q1 | 5.77 Million USD | -14.79% |
| 2023 Q2 | 4.47 Million USD | -6.98% |
| 2023 Q4 | 6.78 Million USD | 88.7% |
| 2023 Q3 | 3.59 Million USD | -19.78% |
| 2023 FY | 6.78 Million USD | -44.95% |
| 2023 Q1 | 4.81 Million USD | -60.9% |
| 2022 FY | 12.31 Million USD | 175.53% |
| 2022 Q4 | 12.31 Million USD | 178.58% |
| 2022 Q2 | 4.33 Million USD | -1.37% |
| 2022 Q1 | 4.39 Million USD | -1.7% |
| 2022 Q3 | 4.42 Million USD | 2.01% |
| 2021 Q2 | 3.64 Million USD | 13.48% |
| 2021 Q1 | 3.21 Million USD | -13.08% |
| 2021 FY | 4.47 Million USD | 21.01% |
| 2021 Q4 | 4.47 Million USD | 8.65% |
| 2021 Q3 | 4.11 Million USD | 12.9% |
| 2020 Q4 | 3.69 Million USD | 8.94% |
| 2020 Q1 | 2.34 Million USD | -35.13% |
| 2020 FY | 3.69 Million USD | 2.27% |
| 2020 Q2 | 3.54 Million USD | 51.13% |
| 2020 Q3 | 3.39 Million USD | -4.24% |
| 2019 Q2 | 2.99 Million USD | 5.61% |
| 2019 Q3 | 3.24 Million USD | 8.42% |
| 2019 Q4 | 3.61 Million USD | 11.28% |
| 2019 FY | 3.61 Million USD | 27.18% |
| 2019 Q1 | 2.83 Million USD | -0.18% |
| 2018 FY | 2.84 Million USD | 28.1% |
| 2018 Q4 | 2.84 Million USD | 32.83% |
| 2018 Q3 | 2.13 Million USD | 0.42% |
| 2018 Q2 | 2.12 Million USD | 5.14% |
| 2018 Q1 | 2.02 Million USD | -8.66% |
| 2017 Q4 | 2.21 Million USD | -6.02% |
| 2017 Q3 | 2.35 Million USD | 2.57% |
| 2017 FY | 2.21 Million USD | -61.2% |
| 2017 Q2 | 2.3 Million USD | -42.07% |
| 2017 Q1 | 3.97 Million USD | -30.52% |
| 2016 Q4 | 5.71 Million USD | 37.32% |
| 2016 FY | 5.71 Million USD | -53.92% |
| 2016 Q2 | 9.3 Million USD | -8.44% |
| 2016 Q1 | 10.16 Million USD | -18.01% |
| 2016 Q3 | 4.16 Million USD | -55.3% |
| 2015 Q4 | 12.39 Million USD | 13.42% |
| 2015 FY | 12.39 Million USD | 292.62% |
| 2015 Q2 | 10.38 Million USD | 19.11% |
| 2015 Q3 | 10.93 Million USD | 5.23% |
| 2015 Q1 | 8.72 Million USD | 176.19% |
| 2014 Q1 | 2.66 Million USD | -23.87% |
| 2014 FY | 3.15 Million USD | -9.85% |
| 2014 Q4 | 3.15 Million USD | 15.72% |
| 2014 Q3 | 2.72 Million USD | -4.21% |
| 2014 Q2 | 2.84 Million USD | 6.82% |
| 2013 Q3 | 2.95 Million USD | 31.2% |
| 2013 Q2 | 2.25 Million USD | 11.44% |
| 2013 Q1 | 2.01 Million USD | -3.26% |
| 2013 FY | 3.5 Million USD | 67.85% |
| 2013 Q4 | 3.5 Million USD | 18.67% |
| 2012 Q4 | 2.08 Million USD | -8.1% |
| 2012 FY | 2.08 Million USD | -26.38% |
| 2012 Q2 | 2.26 Million USD | 10.4% |
| 2012 Q1 | 2.04 Million USD | -27.85% |
| 2012 Q3 | 2.27 Million USD | 0.4% |
| 2011 Q4 | 2.84 Million USD | 121.88% |
| 2011 Q2 | 572.2 Thousand USD | 0.0% |
| 2011 FY | 2.83 Million USD | 519.63% |
| 2011 Q3 | 1.28 Million USD | 123.7% |
| 2010 FY | 457.53 Thousand USD | 32.4% |
| 2010 Q4 | 759.39 Thousand USD | 0.0% |
| 2010 Q2 | 457.53 Thousand USD | 0.0% |
| 2009 Q4 | 315.3 Thousand USD | 0.0% |
| 2009 FY | 345.55 Thousand USD | 48.3% |
| 2009 Q2 | 345.55 Thousand USD | 0.0% |
| 2008 Q2 | 233.01 Thousand USD | 0.0% |
| 2008 Q4 | 887.83 Thousand USD | 0.0% |
| 2008 FY | 233.01 Thousand USD | 6.58% |
| 2007 FY | 218.62 Thousand USD | -40.35% |
| 2007 Q2 | 218.62 Thousand USD | 0.0% |
| 2007 Q4 | 335.08 Thousand USD | 0.0% |
| 2006 Q4 | 981.04 Thousand USD | 0.0% |
| 2006 Q2 | 366.53 Thousand USD | 0.0% |
| 2006 FY | 366.53 Thousand USD | 8.64% |
| 2005 FY | 337.38 Thousand USD | -73.43% |
| 2005 Q4 | 392.61 Thousand USD | 0.0% |
| 2005 Q2 | 337.38 Thousand USD | 0.0% |
| 2004 FY | 1.26 Million USD | 687.14% |
| 2004 Q4 | 8.81 Million USD | 0.0% |
| 2004 Q2 | 1.26 Million USD | 0.0% |
| 2003 FY | 161.33 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 86.772% |
| BrainsWay Ltd. | 15.31 Million USD | 55.727% |
| Cerus Corporation | 144.3 Million USD | 95.302% |
| Envoy Medical, Inc. | 9.4 Million USD | 27.888% |
| electroCore, Inc. | 8.94 Million USD | 24.203% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -26.919% |
| IceCure Medical Ltd | 4.24 Million USD | -59.642% |
| Inogen, Inc. | 121.38 Million USD | 94.414% |
| OrthoPediatrics Corp. | 72.56 Million USD | 90.656% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 77.08% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -113.077% |
| MaxCyte, Inc. | 36.1 Million USD | 81.222% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -266.901% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1494.24% |
| Orthofix Medical Inc. | 326.58 Million USD | 97.924% |
| PAVmed Inc | 57.13 Million USD | 88.134% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 73.373% |
| RxSight, Inc. | 22.18 Million USD | 69.443% |
| Sight Sciences, Inc. | 46.43 Million USD | 85.399% |
| SI-BONE, Inc. | 61.05 Million USD | 88.894% |
| TELA Bio, Inc. | 59.16 Million USD | 88.541% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 94.051% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 34.296% |
| Acutus Medical, Inc. | 54.83 Million USD | 87.637% |
| Talis Biomedical Corporation | 29.22 Million USD | 76.8% |
| Spectral AI, Inc. | 12.4 Million USD | 45.327% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 70.692% |
| CVRx, Inc. | 39.28 Million USD | 82.74% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 43.302% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -179.093% |
| Bioventus Inc. | 589.79 Million USD | 98.85% |
| Venus Concept Inc. | 107.1 Million USD | 93.67% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 86.876% |
| LivaNova PLC | 1.15 Billion USD | 99.411% |
| 908 Devices Inc. | 37.49 Million USD | 81.915% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.036% |
| Nemaura Medical Inc. | 26.37 Million USD | 74.296% |
| NeuroPace, Inc. | 86.99 Million USD | 92.207% |
| LENSAR, Inc. | 22.4 Million USD | 69.744% |
| Apyx Medical Corporation | 52.31 Million USD | 87.041% |
| Cutera, Inc. | 518.12 Million USD | 98.691% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 76.882% |
| BioSig Technologies, Inc. | 4.68 Million USD | -44.717% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 88.384% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 68.448% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.691% |
| Axonics, Inc. | 82.35 Million USD | 91.768% |
| Outset Medical, Inc. | 190.91 Million USD | 96.449% |
| IRIDEX Corporation | 24.91 Million USD | 72.786% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 94.531% |
| IRadimed Corporation | 20.73 Million USD | 67.303% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -305.018% |
| INVO Bioscience, Inc. | 19.99 Million USD | 66.091% |
| Telesis Bio, Inc. | 40.87 Million USD | 83.412% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 83.378% |
| Varex Imaging Corporation | 668.6 Million USD | 98.986% |
| Quipt Home Medical Corp. | 136.29 Million USD | 95.025% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -89.81% |
| Pulmonx Corporation | 60.63 Million USD | 88.819% |
| Dynatronics Corporation | 11.78 Million USD | 42.445% |
| Modular Medical, Inc. | 2.27 Million USD | -198.415% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -66.831% |
| Semler Scientific, Inc. | 6.27 Million USD | -8.134% |
| InMode Ltd. | 75.91 Million USD | 91.069% |
| Bruker Corporation | 2.83 Billion USD | 99.761% |
| Cytosorbents Corporation | 29.98 Million USD | 77.389% |
| DexCom, Inc. | 4.19 Billion USD | 99.838% |
| Align Technology, Inc. | 2.45 Billion USD | 99.724% |
| Viveve Medical, Inc. | 10.84 Million USD | 37.494% |
| ZimVie Inc. | 795.85 Million USD | 99.148% |
| Movano Inc. | 5.97 Million USD | -13.53% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 93.518% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1494.24% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 43.302% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 98.939% |
| Profound Medical Corp. | 12.66 Million USD | 46.47% |
| Insulet Corporation | 1.85 Billion USD | 99.635% |
| enVVeno Medical Corporation | 2.43 Million USD | -178.439% |
| Surmodics, Inc. | 65.82 Million USD | 89.7% |
| iCAD, Inc. | 8 Million USD | 15.261% |
| Biotricity, Inc. | 35.91 Million USD | 81.124% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 96.96% |
| Aethlon Medical, Inc. | 2.47 Million USD | -173.426% |
| InspireMD, Inc. | 8.14 Million USD | 16.728% |
| PAVmed Inc. | 57.13 Million USD | 88.134% |
| BIOLASE, Inc. | 35.34 Million USD | 80.819% |
| Beyond Air, Inc. | 29.77 Million USD | 77.229% |
| FONAR Corporation | 57.45 Million USD | 88.2% |
| AxoGen, Inc. | 101.16 Million USD | 93.298% |
| Vivani Medical, Inc. | 25.03 Million USD | 72.919% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 92.278% |
| Inari Medical, Inc. | 209.32 Million USD | 96.761% |
| UFP Technologies, Inc. | 118.04 Million USD | 94.256% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 46.574% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -210.182% |
| Tenon Medical, Inc. | 5.56 Million USD | -21.789% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -281.113% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 61.552% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.785% |
| Sintx Technologies, Inc. | 6.59 Million USD | -2.836% |
| NanoVibronix, Inc. | 2.68 Million USD | -152.42% |
| Quanterix Corporation | 78.08 Million USD | 91.317% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -89.81% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -38.792% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.351% |
| TransMedics Group, Inc. | 568.84 Million USD | 98.808% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 59.357% |
| NeuroMetrix, Inc. | 1.33 Million USD | -408.58% |
| Hyperfine, Inc. | 9.8 Million USD | 30.816% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 97.291% |
| Biomerica, Inc. | 2.66 Million USD | -154.6% |
| Bone Biologics Corporation | 831.4 Thousand USD | -715.49% |
| AVITA Medical, Inc. | 19.86 Million USD | 65.87% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -243.52% |
| Silk Road Medical, Inc | 114.15 Million USD | 94.061% |